THE RATE OF GASTRIC FUNCTIONAL POLYPS AND SOME RELATED FACTORS

Thúy Hằng Bùi, Thị Vân Hồng Nguyễn

Main Article Content

Abstract

Gastric fundic gland polyps (FGPs) are the most common type of gastric polyps detected during upper gastrointestinal endoscopy. The rate of Helicobacter pylori infection and the use of proton pump inhibitors (PPIs) are considered to be related to gastric fundic gland polyps. Aims: 1. To survey the rate of gastric fundic gland polyps in patients undergoing upper gastrointestinal endoscopy. 2. To determine the rate of H. pylori infection and some related factors. Materials and method: Prospective descriptive study on 483 patients histologically diagnosed as gastric fundic gland polyps according to WHO 2019 standards, undergoing upper gastrointestinal endoscopy at the Digestive Endoscopy Department, Vietnam-Sweden Hospital, Uong Bi, Quang Ninh from July 2023 to the end of June 2024. Results: The rate of gastric fundic gland polyps in 15,458 upper gastrointestinal endoscopy cases was 3.12%; The mean age was 55.9 ± 12.7; 28% were male, 72% were female; FGP < 5mm was 2.6%, 5mm ≤ FGP ≤10mm was 0.5%, FGP >10mm was 0.02%; The rate of H.Pylori infection in patients with gastric fundus polyps was 24.4%. Regarding the factor of PPI use: 16% were not identified for PPI use, 17% were not identified for PPI use and 67% were identified for PPI use. Of the group that used PPI, 28% used it for less than 1 year, 61% used it for 1-5 years and 11% used it for more than 5 years. Conclusion: In 15,458 upper gastrointestinal endoscopy cases, 3.12% of patients were diagnosed with gastric fundus polyps, common in middle-aged women. Gastric fundic gland polyps have a low prevalence of H. pylori infection and are associated with a history of proton pump inhibitor (PPI) use

Article Details

References

Samarasam I, Roberts-Thomson J, Brockwell D. Gastric fundic gland polyps: a clinico-pathological study from North West Tasmania. ANZ J Surg. 2009;79(6):467-470. doi:10.1111/j.1445-2197.2009.04948.x
2. Rubio CA, Nesi G. Fundic Gland Polyps. Anticancer Res. 2011;31(5):1789-1793.
3. Lee PL, Chen JJ, Wang SJ, Tung HD, Cheng CT, Lu NM. Fundic gland polyps is more common in patients with relative healthy gastric mucosa. Adv Dig Med. 2018;5(1-2):44-49. doi:10.1002/ aid2.13075
4. Brito HL de F, Barros C, Freire MV, Silva Filho MN da, Nascimento TV. GASTRIC FUNDIC GLAND POLYPS: CAN HISTOLOGY BE USEFUL TO PREDICT PROTON PUMP INHIBITORS USE? Arq Gastroenterol. 2018;55(4):380-384. doi:10.1590/S0004-2803.201800000-82
5. Huang CZ, Lai RX, Mai L, Zhou HL, Chen HJ, Guo HX. Relative risk factors associated with the development of fundic gland polyps. Eur J Gastroenterol Hepatol. 2014;26(11):1217-1221. doi:10.1097/MEG.0000000000000199
6. Gao W, Huang Y, Lu S, Li C. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors. Ann Palliat Med. 2021;10(2):2108-2114. doi:10.21037/apm-21-39
7. Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116(5):716-720. doi:10.1309/ XFWR-LXA7-7TK1-N3Q8
8. Martin FC, Chenevix-Trench G, Yeomans ND. Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors. Aliment Pharmacol Ther. 2016;44(9):915-925. doi:10. 1111/apt.13800